AI assistant
USCOM LIMITED — Regulatory Filings 2011
May 12, 2011
65979_rns_2011-05-12_ae90073b-231e-4db9-ab4e-d51104a05929.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au
M A R K E T A N N O U N C E M E N T
Uscom advances into Europe
Uscom Ltd (ASX code UCM) today announced that it had established a significant presence in Europe with the appointment of two important distributors, Genesys Medical Solutions (UK) and DutchMed (Eastern Europe).
Whilst the UK already has several impressive reference sites for Uscom, Genesys will now leverage these to extend our reach across the entire country.
DutchMed, have developed a strong sales organisation covering Bulgaria, Romania, Moldavia, Hungary, Poland and Slovakia.
Both organisations have sound experience in selling innovative healthcare products into those hospital departments where Uscom is finding best traction in Paediatrics, Emergency and Intensive Care.
Uscom’s Executive Chairman, Mr Kiely said,”I have met the principals of both these organisations and have confidence in their ability to quickly exploit the opportunities for Uscom. Each have developed credible sales operations with knowledge of patient monitoring devices and well established contacts with clinicians who can make use of our monitor. It is also imperative that we begin to advance our offering into the burgeoning markets of Eastern Europe.
Uscom has also signed up Prhoinsa to cover its Spanish opportunities and is currently in negotiation with several companies in Germany. It has previously announced the appointment of Vok Medical Systems to cover the Russian market.
About Uscom
Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor which measures critical performance indicators of haemodynamics. The USCOM 1A is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a potential new standard in the management of adult and paediatric sepsis, and for the guidance of all fluid and drug therapy administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India and Australia & New Zealand through its distributors in Asia .
Uscom Contacts
Phil Kiely Executive Chairman [email protected]
Daniel Fah Company Secretary [email protected]